Category : Fecal Microbiota Transplant

Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although previous small not blinded studies and one randomized placebo-controlled study have looked at the effectiveness of fecal microbiota transplantation (FMT) in patients with IBS, its utility in these patients remains unknown. A new randomized, double-blind placebo-controlled study, led by…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous research has shown that some subgroups of patients with irritable bowel syndrome (IBS) exhibit a different gut microbiota composition. Although previous small not blinded studies and one randomized placebo-controlled study have looked at the effectiveness of fecal microbiota transplantation (FMT) in patients with IBS, its utility in these patients remains unknown. A new randomized, double-blind placebo-controlled study, led by…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

This post is a shortened version of the original article published in Science Trends on July 11, 2018. If – for whatever reason – a single toxic bacterial species – Clostridium difficile (C-diff) – has taken over your entire gut ecosystem, has banished many of the commensal gut bacteria needed for a healthy life, and does not respond any longer…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

This post is a shortened version of the original article published in Science Trends on July 11, 2018. If – for whatever reason – a single toxic bacterial species – Clostridium difficile (C-diff) – has taken over your entire gut ecosystem, has banished many of the commensal gut bacteria needed for a healthy life, and does not respond any longer…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Hepatic steatosis is a multifactorial condition related to obesity that may contribute to the development of virus-associated and non-alcoholic fatty liver disease (NAFLD) in humans, in which patients usually start to show symptoms when the disease is in its advanced stages. Although the gut microbiome has recently evolved as a new and important player in the pathophysiology of liver diseases,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Hepatic steatosis is a multifactorial condition related to obesity that may contribute to the development of virus-associated and non-alcoholic fatty liver disease (NAFLD) in humans, in which patients usually start to show symptoms when the disease is in its advanced stages. Although the gut microbiome has recently evolved as a new and important player in the pathophysiology of liver diseases,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN).  Organized by the International Union of Nutritional Sciences (IUNS) with the theme “From Sciences to Nutrition Security”, the event will take place at the Hotel Sheraton, Buenos Aires (Argentina) from October 15th to 20th, 2017. IUNS promotes advancement in nutrition science, research,…

GMFH Editing Team
GMFH Editing Team

Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN).  Organized by the International Union of Nutritional Sciences (IUNS) with the theme “From Sciences to Nutrition Security”, the event will take place at the Hotel Sheraton, Buenos Aires (Argentina) from October 15th to 20th, 2017. IUNS promotes advancement in nutrition science, research,…

GMFH Editing Team
GMFH Editing Team

Constipation is a common condition that may result from altered gastrointestinal motility. Several factors appear relevant to gut motility: the gut luminal environment (including the gastrointestinal microbiota and fermentation), as well as factors related to the immune system, the enteric nervous system, and the central nervous system. Previous research has found associations between colonic transit time and aspects of patients’…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Constipation is a common condition that may result from altered gastrointestinal motility. Several factors appear relevant to gut motility: the gut luminal environment (including the gastrointestinal microbiota and fermentation), as well as factors related to the immune system, the enteric nervous system, and the central nervous system. Previous research has found associations between colonic transit time and aspects of patients’…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both therapeutic and adverse effects of metformin, which is the most prescribed drug for the treatment of individuals with type 2…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

It is well-known that medications could affect the microbiome and therefore host-microbiota interactions are considered a confounding factor that can contribute to therapeutic and side effects of drug treatments. Previous research has shown that gut microbiota may partially mediate both therapeutic and adverse effects of metformin, which is the most prescribed drug for the treatment of individuals with type 2…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

For those seeking the latest science on gut health and its applications to clinical practice, Paris was the place to be on March 11th and 12th, 2017. At the 6th GMFH World Summit, over 400 professionals from all over the world met to review the past decade of advances in gut microbiota science and where the field is headed in…

GMFH Editing Team
GMFH Editing Team

For those seeking the latest science on gut health and its applications to clinical practice, Paris was the place to be on March 11th and 12th, 2017. At the 6th GMFH World Summit, over 400 professionals from all over the world met to review the past decade of advances in gut microbiota science and where the field is headed in…

GMFH Editing Team
GMFH Editing Team

Faecal microbiota transplantation (FMT) is currently investigated as a novel treatment option for several chronic diseases related to gut dysbiosis with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although clear reporting of FMT methodology is important to better understand and reproduce studies, reports of the methodological components of FMT interventions in clinical trials vary…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Faecal microbiota transplantation (FMT) is currently investigated as a novel treatment option for several chronic diseases related to gut dysbiosis with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although clear reporting of FMT methodology is important to better understand and reproduce studies, reports of the methodological components of FMT interventions in clinical trials vary…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Faecal microbiota transplantation (FMT) has been previously reported as an effective treatment for recurrent Clostridium difficile infection (rCDI). Preclinical and clinical data have shown that restoration of donor-like beta diversity (i.e. species diversity compared to another individual) did not always correspond to direct restoration of an individual’s alpha diversity (i.e. the mean species diversity on a local scale), which suggests…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Faecal microbiota transplantation (FMT) has been previously reported as an effective treatment for recurrent Clostridium difficile infection (rCDI). Preclinical and clinical data have shown that restoration of donor-like beta diversity (i.e. species diversity compared to another individual) did not always correspond to direct restoration of an individual’s alpha diversity (i.e. the mean species diversity on a local scale), which suggests…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados